Pancreatic Cancer Research

ResearcherLeidos Biomedical Research Inc. (United States)No recent work listed

Christopher Westlake

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7476-2014; OpenAlex author ID A5027484716; NIH RePORTER profile ID 11142389. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
2
Labs led
0
Collaborators
9
Papers, trials and grants by year

2013: 1 grant · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 grant · 2021: 1 paper

Papers 2

  1. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  2. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-3176↗

Grants 2

  1. Regulation of Ciliogenesis and Ciliary-related signaling ZIABC011398↗
  2. Investigation of Rabs and trafficking regulators roles in tumorigenesis ZIABC011416↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wendy Cozen · 1 shared paper, 2014 · strength 0.03
  2. Charles F. Lynch · 1 shared paper, 2014 · strength 0.03
  3. Lizhi Zhang · 1 shared paper, 2014 · strength 0.03
  4. Jason W. Hoskins · 1 shared paper, 2014 · strength 0.03
  5. Stephen M. Hewitt · 1 shared paper, 2014 · strength 0.03
  6. Hemang M. Parikh · 1 shared paper, 2014 · strength 0.03
  7. Jinping Jia · 1 shared paper, 2014 · strength 0.03
  8. Laufey Thora Amundadottir · 1 shared paper, 2014 · strength 0.03
  9. Gloria M. Petersen · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.